Trial reportSchizophrenia bulletin2018
Embracing Psychosis: A Cognitive Insight Intervention Improves Personal Narratives and Meaning-Making in Patients With Schizophrenia.
Trial report in Schizophrenia bulletin, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 1 synthesis or guideline pooled it, 55 citations in OpenAlex.
- Can metacognitive interventions improve insight in schizophrenia spectrum disorders? A systematic review and meta-analysis.Psychological medicine · 2020Pooled it
- Increased regional homogeneity modulated by metacognitive training predicts therapeutic efficacy in patients with schizophrenia.European archives of psychiatry and clinical neuroscience · 2021Trial
- Mapping Psychosocial Interventions for Psychosis and Schizophrenia Across Gulf Countries: A Scoping and Narrative Review.Journal of clinical medicine · 2026Review
- Does neurocognition predict personal recovery over time in psychotic disorder patients?Schizophrenia research. Cognition · 2026Article
- Article
- No Sex-based Differences in Self-reported Empathy between Patients with Schizophrenia and Control Subjects.Actas espanolas de psiquiatria · 2024Article
- Article
- A cognitive-behavioral suicide prevention treatment for adults with schizophrenia spectrum disorders in community mental health: Preliminary findings of an open pilot study.Social work in mental health · 2023Article
- Heterogeneity in Response to MCT and Psychoeducation: A Feasibility Study Using Latent Class Mixed Models in First-Episode Psychosis.Healthcare (Basel, Switzerland) · 2022Article
- Time in schizophrenia: a link between psychopathology, psychophysics and technology.Translational psychiatry · 2022Review
- Modifying a cognitive behavioral suicide prevention treatment for adults with schizophrenia spectrum disorders in community mental health.Psychiatry research · 2022Article
- The relative contributions of insight and neurocognition to intrinsic motivation in schizophrenia.Schizophrenia (Heidelberg, Germany) · 2022Article
- Internalized stigma mediates the relation between psychosis-risk symptoms and subjective quality of life in a help-seeking sample.Schizophrenia research · 2022Article
- Article
- Influence of Social Workers' Empathy Ability on Suicidal Ideation of Cancer Patients.Frontiers in public health · 2022Article
- Metacognition, social cognition, and mentalizing in psychosis: are these distinct constructs when it comes to subjective experience or are we just splitting hairs?BMC psychiatry · 2021Review
- Social Dysfunction in Psychosis Is More Than a Matter of Misperception: Advances From the Study of Metacognition.Frontiers in psychology · 2021Review
- Cognitive Insight in First-Episode Psychosis: Changes during Metacognitive Training.Journal of personalized medicine · 2020Article
- The Role of Personal Identity on Positive and Negative Symptoms in Psychosis: A Study Using the Repertory Grid Technique.Schizophrenia bulletin · 2020Article
- Schizophrenia, recovery and the self: An introduction to the special issue on metacognition.Schizophrenia research. Cognition · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 3 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Schizophrenia is a complex psychiatric disorder with unknown and presumably heterogeneous etiology. While the disorder can have various outcomes, research is predominantly "deficit-oriented" emphasizing the hardship that the disorder inflicts on sufferers as well as their families and society. Beyond symptom reduction, imparting patients with hope and meaning in life is increasingly considered an important treatment target, which may raise self-esteem, and reduce self-stigma and suicidal ideation. The present study compared a psychotherapeutic treatment aimed at improving cognitive insight, individualized metacognitive intervention (MCT+), with an active control in order to elucidate if personal meaning-making and hope can be improved in patients with psychosis across time. A total of 92 patients were randomized to either individualized metacognitive therapy (MCT+) or CogPack (neuropsychological training) and followed up for up to 6 months. The "Subjective Sense in Psychosis Questionnaire" (SUSE) was administered which covers different salutogenetic vs pathogenetic views of the disorder, valence of symptom experiences and the consequences of psychosis. Patients in the MCT+ group showed a significant positive shift in attitudes towards the consequences of their illness over time relative to patients in the active control condition. There was some evidence that MCT+ also enhanced meaning-making. The perceived negative consequences of psychosis were highly correlated with depression and low self-esteem, as well as suicidality. The study shows that a cognitive insight training can improve meaning-making in patients and help them come to terms with their diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.